Source 20240722_182535
Canonical Links
| item | link |
|---|
| Direct transcription | 20240722_182535 |
| Raw photo | data/raw/photos/20240722_182535.jpg |
| field | value |
|---|
| Page label | Page 359 of 365 |
| Navigation path | Pipeline of GD & GBA-PD > Supplement > Mutations SNCA > Neurodegeneration and aSyn > Oligodendrocytic aSyn > PET aSyn |
| Section | GBA-PD, GD, and α-Synuclein Pipeline |
| Uncertain spans | 0 |
| Embedded images | 0 |
| Related photos | 2 |
Headings
- PET aSyn — QST Specified Clinical Trial planning (Operational lead, Funding MJF, Schedule, IND, Goal, Protocol, Process, Contract, Freedom to operate, GLP-Tox)
- QST Specified Clinical Trial — planning (PET aSyn vendor matrix continuation)
Wiki Coverage
Topic-level synthesis should link back to this source note or directly to the canonical transcription when making specific claims.